P670: EARLY CYTOGENETIC OR MOLECULAR LANDMARK RESPONSE TO PONATINIB TREATMENT PREDICTS OUTCOMES IN HEAVILY PRETREATED PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA IN PACE: 5-YEAR DATA

Detalles Bibliográficos
Autores principales: Müller, Martin C., Cortes, Jorge, Chuah, Charles, Deangelo, Daniel, Deininger, Michael, Guilhot, François, Hughes, Timothy, Emmanuel Nicolini, Franck, Pinilla-Ibarz, Javier, Rea, Delphine, Rosti, Gianantonio, Shah, Neil P., Talpaz, Moshe, Lu, Vickie, Padukkavidana, Thihan, Kantarjian, Hagop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428931/
http://dx.doi.org/10.1097/01.HS9.0000969584.88427.a9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428931/
http://dx.doi.org/10.1097/01.HS9.0000969584.88427.a9

Ejemplares similares